z-logo
open-access-imgOpen Access
Two cases of von Willebrand disease type 3 in consanguineous Chinese families
Author(s) -
Wang Xiong,
Tang Ning,
Lu Yanjun,
Hu Qun,
Li Dengju
Publication year - 2020
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.1075
Subject(s) - von willebrand disease , sanger sequencing , von willebrand factor , medicine , consanguinity , compound heterozygosity , nonsense mutation , family history , consanguineous marriage , pediatrics , nonsense , heterozygote advantage , genetics , mutation , genotype , gene , missense mutation , biology , platelet
Abstract Background von Willebrand disease (VWD) is the most common inherited bleeding disorder caused by defective or deficient von Willebrand factor (VWF). VWD type 3 is inherited in autosomal recessive manner. We described clinical and molecular features of VWD type 3 in two consanguineous marriage families. Methods Peripheral blood was collected, PT, APTT, FVIII:C, VWF:RCo, VWF:Ag were measured. A targeted next‐generation sequencing panel covering F8 , F9 , and VWF genes was applied followed by Sanger sequencing. Results Both families had a baby die in their first year due to bleeding disorders. A 23‐year‐old female patient from family A suffered menorrhagia, and another 30‐year‐old male patient from family B was characterized with hematoma in the lower extremity. Both patients showed severely decreased FVIII:C, VWF:Ag. Recurrent homozygous VWF c.4696C>T (p.Arg1566Ter) nonsense mutation was identified in the female patient, and novel homozygous VWF c.6450C>A (p.Cys2150Ter) nonsense mutation was identified the male patient. Heterozygotes in family members showed mild/moderate decrease in VWF:Ag or VWF:RCo. Conclusions We identified VWD type 3 in two consanguineous marriage families, and our work further strengthen the risk of delivering disorders inherited in AR manner in populations with frequent consanguineous partnerships.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here